Treatment of Complicated UTI in Female Adult with ESBL E. coli and Nephrostomy
Understanding the Condition
- The presence of ESBL-producing organisms is a factor associated with complicated UTIs, according to the European Urology guidelines 1
- Complicated UTIs are defined as infections occurring in patients with underlying structural or medical problems, including foreign bodies, urinary tract obstruction, and indwelling catheters 3
- The case represents a complicated UTI due to both the presence of ESBL-producing E. coli and the nephrostomy tube, which is considered a foreign body and structural abnormality of the urinary tract 1, 2
Initial Assessment and Management
- Obtain urine culture and susceptibility testing before initiating antimicrobial therapy to guide targeted treatment, as recommended by the European Urology guidelines 1, 4
- Assess severity of illness and hemodynamic stability to determine if inpatient or outpatient management is appropriate 1
- Management of the underlying urological abnormality, such as ensuring proper nephrostomy function, is mandatory alongside antimicrobial therapy 1
Antimicrobial Treatment Options
- Carbapenems, such as meropenem, are considered highly effective against ESBL-producing organisms, with a recommended dosage of 1g three times daily 1
- The European Urology guidelines recommend treatment for 7-14 days for complicated UTIs 1, 2
Special Considerations
- Avoid fluoroquinolones for empiric treatment due to increasing resistance rates, especially in ESBL-producing organisms 1
- Consider removal or exchange of the nephrostomy tube if clinically indicated, as foreign bodies can serve as a nidus for persistent infection 1, 3
- Monitor for clinical improvement within 48-72 hours of initiating appropriate antimicrobial therapy 1